Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients

Neurobiology of Aging

Volumn 33, Issue 8, 2012, Pages 1850.e17-1850.e27

  Lohmann, Ebba ^a   Guerreiro, Rita J ^b,c,d   Erginel Unaltuna, Nihan ^a   Gurunlian, Nicole ^c   Bilgic, Basar ^a   Gurvit, Hakan ^a   Hanagasi, Hasmet A ^a   Luu, Nga ^d   Emre, Murat ^a   Singleton, Andrew ^d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer disease; Mutation; Presenilin; Turkey

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PSEN1 GENE; PSEN2 GENE; SEIZURE; SPASTICITY; TURKEY (REPUBLIC); DEMENTIA; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PREVALENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; DEMENTIA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRESENILIN-1; PREVALENCE; RISK FACTORS; TURKEY;

EID: 84861907299     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.02.020     Document Type: Article

References (51)

1. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer's disease. Lancet 2011, 377:1019-1031.
3. Boteva K., Vitek M., Mitsuda H., de Silva H., Xu P.T., Small G., Gilbert J.R. Mutation analysis of presenillin 1 gene in Alzheimer's disease. Lancet 1996, 347:130-131.
4. Brouwers N., Sleegers K., Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann. Med 2008, 40:562-583.
5. Campion D., Dumanchin C., Hannequin D., Dubois B., Belliard S., Puel M., Thomas-Anterion C., Michon A., Martin C., Charbonnier F., Raux G., Camuzat A., Penet C., Mesnage V., Martinez M., Clerget-Darpoux F., Brice A., Frebourg T. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet 1999, 65:664-670.
6. Campion D., Flaman J.M., Brice A., Hannequin D., Dubois B., Martin C., Moreau V., Charbonnier F., Didierjean O., Tardieu S., et al. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet 1995, 4:2373-2377.
7. Chibnik L.B., Shulman J.M., Leurgans S.E., Schneider J.A., Wilson R.S., Tran D., Aubin C., Buchman A.S., Heward C.B., Myers A.J., Hardy J.A., Huentelman M.J., Corneveaux J.J., Reiman E.M., Evans D.A., Bennett D.A., De Jager P.L. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann. Neurol 2011, 69:560-569.
8. Cruts M., van Duijn C.M., Backhovens H., Van den Broeck M., Wehnert A., Serneels S., Sherrington R., Hutton M., Hardy J., St George-Hyslop P.H., Hofman A., Van Broeckhoven C. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum. Mol. Genet 1998, 7:43-51.
9. Di Fede G., Catania M., Morbin M., Rossi G., Suardi S., Mazzoleni G., Merlin M., Giovagnoli A.R., Prioni S., Erbetta A., Falcone C., Gobbi M., Colombo L., Bastone A., Beeg M., Manzoni C., Francescucci B., Spagnoli A., Cantù L., Del Favero E., Levy E., Salmona M., Tagliavini F. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 2009, 323:1473-1477.
10. Dubois B., Burn D., Goetz C., Aarsland D., Brown R.G., Broe G.A., Dickson D., Duyckaerts C., Cummings J., Gauthier S., Korczyn A., Lees A., Levy R., Litvan I., Mizuno Y., McKeith I.G., Olanow C.W., Poewe W., Sampaio C., Tolosa E., Emre M. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov. Disord 2007, 22:2314-2324.
11. Dumanchin C., Tournier I., Martin C., Didic M., Belliard S., Carlander B., Rouhart F., Duyckaerts C., Pellissier J.F., Latouche J.B., Hannequin D., Frebourg T., Tosi M., Campion D. Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques. Hum. Mutat 2006, 27:1063.
12. Finckh U., Kuschel C., Anagnostouli M., Patsouris E., Pantes G.V., Gatzonis S., Kapaki E., Davaki P., Lamszus K., Stavrou D., Gal A. Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 2005, 6:85-89.
13. Forsell C., Froelich S., Axelman K., Vestling M., Cowburn R.F., Lilius L., Johnston J.A., Engvall B., Johansson K., Dahlkild A., Ingelson M., St George-Hyslop P.H., Lannfelt L. A novel pathogenic mutation (Leu262Phe) found in the presenilin 1 gene in early-onset Alzheimer's disease. Neurosci. Lett 1997, 234:3-6.
14. Frank A.R., Petersen R.C. Alzheimer disease-Mild cognitive impairment. Handbook of Clinical Neurology--Dementias 2008, Volume 89, third series:217-221. Elsevier, New York.
15. Gallo M., Tomaino C., Puccio G., Frangipane F., Curciom S.A., Bernardi L., Geracitano S., Anfossi M., Mirabelli M., Colao R., Vasso F., Smirne N., Maletta R.G., Bruni A.C. Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia. Neurol. Sci 2010, 31:65-70.
16. Giaccone G., Morbin M., Moda F., Botta M., Mazzoleni G., Uggetti A., Catania M., Moro M.L., Redaelli V., Spagnoli A., Rossi R.S., Salmona M., Di Fede G., Tagliavini F. Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features. Acta Neuropathol 2010, 120:803-812.
17. Goldman J.S., Hahn S.E., Catania J.W., LaRusse-Eckert S., Butson M.B., Rumbaugh M., Strecker M.N., Roberts J.S., Burke W., Mayeux R., Bird T. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet. Med 2011, 13:597-605. American College of Medical Genetics and the National Society of Genetic Counselors.
18. Gómez-Tortosa E., Barquero S., Barón M., Gil-Neciga E., Castellanos F., Zurdo M., Manzano S., Muñoz D.G., Jiménez-Huete A., Rábano A., Sainz M.J., Guerrero R., Gobernado I., Pérez-Pérez J., Jiménez-Escrig A. Clinical-genetic correlations in familial Alzheimer's disease caused by presenilin 1 mutations. J. Alzheimers Dis 2010, 19:873-884.
19. Guerreiro R.J., Baquero M., Blesa R., Boada M., Brás J.M., Bullido M.J., Calado A., Crook R., Ferreira C., Frank A., Gómez-Isla T., Hernández I., Lleó A., Machado A., Martínez-Lage P., Masdeu J., Molina-Porcel L., Molinuevo J.L., Pastor P., Pérez-Tur J., Relvas R., Oliveira C.R., Ribeiro M.H., Rogaeva E., Sa A., Samaranch L., Sánchez-Valle R., Santana I., Tàrraga L., Valdivieso F., Singleton A., Hardy J., Clarimón J. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol. Aging 2010, 31:725-731.
20. Gurvit H., Emre M., Tinaz S., Bilgic B., Hanagasi H., Sahin H., Gurol E., Kvaloy J.T., Harmanci H. The prevalence of dementia in an urban Turkish population. Am. J. Alzheimers Dis. Other Demen 2008, 23:67-76.
21. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Rüther E., Schürmann B., Heun R., Kölsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Gallacher J., Hüll M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., van Duijn C.M., Breteler M.M., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.F., Tzourio C., Alpérovitch A., Lathrop M., Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Björnsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossù P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet 2011, 43:429-435. Alzheimer's Disease Neuroimaging Initiative, CHARGE ConsortiumCHARGE Consortium, EADI1 consortiumEADI1 consortium.
22. Jacquemont M.L., Campion D., Hahn V., Tallaksen C., Frebourg T., Brice A., Durr A. Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease. J. Med. Genet 2002, 39:E2.
23. Kamimura K., Tanahashi H., Yamanaka H., Takahashi K., Asada T., Tabira T. Familial Alzheimer's disease genes in Japanese. J. Neurol. Sci 1998, 160:76-81.
24. Kamino K., Sato S., Sakaki Y., Yoshiiwa A., Nishiwaki Y., Takeda M., Tanabe H., Nishimura T., Ii K., St.George-Hyslop P.H., Miki T., Ogihara T. Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families. Neurosci. Lett 1996, 208:195-198.
25. Kaneko H., Kakita A., Kasuga K., Nozaki H., Ishikawa A., Miyashita A., Kuwano R., Ito G., Iwatsubo T., Takahashi H., Nishizawa M., Onodera O., Sisodia S.S., Ikeuchi T. Enhanced accumulation of phosphorylated alpha-synuclein and elevated beta-amyloid 42/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease. J. Neurosci 2007, 27:13092-13097.
26. Kwok J.B., Taddei K., Hallupp M., Fisher C., Brooks W.S., Broe G.A., Hardy J., Fulham M.J., Nicholson G.A., Stell R., St.George Hyslop P.H., Fraser P.E., Kakulas B., Clarnette R., Relkin N., Gandy S.E., Schofield P.R., Martins R.N. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 1997, 8:1537-1542.
27. Li D., Parks S.B., Kushner J.D., Nauman D., Burgess D., Ludwigsen S., Partain J., Nixon R.R., Allen C.N., Irwin R.P., Jakobs P.M., Litt M., Hershberger R.E. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Hum. Genet 2006, 79:1030-1039.
28. Lleó A., Blesa R., Queralt R., Ezquerra M., Molinuevo J.L., Peña-Casanova J., Rojo A., Oliva R. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. Arch. Neurol 2002, 59:1759-1763.
29. Martikainen P., Pikkarainen M., Pöntynen K., Hiltunen M., Lehtovirta M., Tuisku S., Soininen H., Alafuzoff I. Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutation. Neuropathol. Appl. Neurobiol 2010, 36:41-54.
30. McKeith I.G. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J. Alzheimers Dis 2006, 9:417-423.
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 77:333.
32. Meyer J., Xu G., Thornby J., Chowdhury M., Quach M. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J. Neurol. Sci 2002, 201:19-25.
33. Nagasaka Y., Dillner K., Ebise H., Teramoto R., Nakagawa H., Lilius L., Axelman K., Forsell C., Ito A., Winblad B., Kimura T., Graff C. A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14854-14859.
34. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St.George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet 2011, 43:436-441.
35. Poduslo S.E., Herring K., Neal M. A presenilin 1 mutation in an early onset Alzheimer's family: no association with presenilin 2. Neuroreport 1996, 7:2018-2020.
36. Poorkaj P., Sharma V., Anderson L., Nemens E., Alonso M.E., Orr H., White J., Heston L., Bird T.D., Schellenberg G.D. Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene. Hum. Mutat 1998, 11:216-221.
37. Raux G., Guyant-Maréchal L., Martin C., Bou J., Penet C., Brice A., Hannequin D., Frebourg T., Campion D. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J. Med. Genet 2005, 42:793-795.
38. Rogaeva E.A., Fafel K.C., Song Y.Q., Medeiros H., Sato C., Liang Y., Richard E., Rogaev E.I., Frommelt P., Sadovnick A.D., Meschino W., Rockwood K., Boss M.A., Mayeux R., St.George-Hyslop P. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology 2001, 57:621-625.
39. Rudzinski L.A., Fletcher R.M., Dickson D.W., Crook R., Hutton M.L., Adamson J., Graff-Radford N.R. Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Dis. Assoc. Disord 2008, 22:299-307.
40. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St..George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
41. Sleegers K., Roks G., Theuns J., Aulchenko Y.S., Rademakers R., Cruts M., van Gool W.A., Van Broeckhoven C., Heutink P., Oostra B.A., van Swieten J.C., van Duijn C.M. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain 2004, 127:1641-1649.
42. Tanahashi H., Kawakatsu S., Kaneko M., Yamanaka H., Takahashi K., Tabira T. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients. Neurosci. Lett 1996, 218:139-141.
43. Tanahashi H., Mitsunaga Y., Takahashi K., Tasaki H., Watanabe S., Tabira T. Missense mutation of S182 gene in Japanese familial Alzheimer's disease. Lancet 1995, 346:440.
44. Tedde A., Nacmias B., Ciantelli M., Forleo P., Cellini E., Bagnoli S., Piccini C., Caffarra P., Ghidoni E., Paganini M., Bracco L., Sorbi S. Identification of new presenilin gene mutations in early-onset familial Alzheimer disease. Arch. Neurol 2003, 60:1541-1544.
45. Clinical and neuropathological criteria for frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 1994, 57:416-418. The Lund and Manchester Groups.
46. Tomaino C., Bernardi L., Anfossi M., Costanzo A., Ferrise F., Gallo M., Geracitano S., Maletta R., Curcio S.A., Mirabelli M., Colao R., Frangipane F., Puccio G., Calignano C., Muraca M.G., Paonessa A., Smirne N., Leotta A., Bruni A.C. Presenilin 2 Ser130Leu mutation in a case of late-onset "sporadic" Alzheimer's disease. J. Neurol 2007, 254:391-393.
47. Tomiyama T., Nagata T., Shimada H., Teraoka R., Fukushima A., Kanemitsu H., Takuma H., Kuwano R., Imagawa M., Ataka S., Wada Y., Yoshioka E., Nishizaki T., Watanabe Y., Mori H. A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Ann. Neurol 2008, 63:377-387.
48. 2009 Census, Population statistics access in 2009 2010, Turkish Statistical Institute. http://www.turkstat.gov.tr.
49. Walker E.S., Martinez M., Brunkan A.L., Goate A. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios. J. Neurochem 2005, 92:294-301.
50. Wasco W., Pettingell W.P., Jondro P.D., Schmidt S.D., Gurubhagavatula S., Rodes L., DiBlasi T., Romano D.M., Guenette S.Y., Kovacs D.M., Growdon J.H., Tanzi R.E. Familial Alzheimer's chromosome 14 mutations. Nat. Med 1995, 1:848.
51. Zekanowski C., Styczyńska M., Pepłońska B., Gabryelewicz T., Religa D., Ilkowski J., Kijanowska-Haładyna B., Kotapka-Minc S., Mikkelsen S., Pfeffer A., Barczak A., Łuczywek E., Wasiak B., Chodakowska-Zebrowska M., Gustaw K., Łaczkowski J., Sobów T., Kuźnicki J., Barcikowska M. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland. Exp. Neurol 2003, 184:991-996.